PMID: 14590642Nov 1, 2003Paper

A review of the neuropsychological effects of commonly used prescription medications

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
R A Stein, T L Strickland

Abstract

The practice of clinical neuropsychology has traditionally accorded limited attention to the impact of prescription medications on cognitive functioning. Though neuropsychologists see a wide array of patients with cerebropathologic and other organ system disease that are under pharmacotherapy, systematic attention to how these compounds potentially affect neuropsychological functioning has lagged. Psychomotor functioning, concentration, and memory are the most common cognitive domains negatively affected by such medications. In general sedative, psychomotor, and, to a lesser extent, attention/concentration effects covary and typically show tolerance with sustained drug administration. Memory effects are more resistant probably due to ongoing anticholinergic effects and the established link between the cholinergic system and memory functioning. This review covers the basic science and clinical literature addressing neuropsychological functioning both in healthy nonpatients and in patients treated with antidepressants, anxiolytics, stimulants, antihypertensives, antiepileptics and antihistamines. Critical to the understanding of the effects of these agents is the integration of multiple factors that modulate medication-induced ne...Continue Reading

References

Feb 1, 1975·The Journal of Clinical Investigation·U KlotzG R Wilkinson
Jun 1, 1992·International Clinical Psychopharmacology·A M Johnson
Oct 1, 1992·The Nurse Practitioner·S L Mejo
Jan 1, 1992·Journal of Cardiovascular Pharmacology·C J Bulpitt, A E Fletcher
May 1, 1991·American Journal of Public Health·M SwartzK Smith
Jun 1, 1991·Journal of Hypertension·M F MuldoonS R Waldstein
Jun 1, 1991·The Japanese Journal of Psychiatry and Neurology·H EnokiS Ohtahara
Jan 1, 1991·International Clinical Psychopharmacology·D KeeganA Boulton
Apr 1, 1990·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·E O Meltzer
Jun 1, 1991·Journal of Clinical Psychopharmacology·C T GualtieriM Chandler
Apr 1, 1990·Acta Neurologica Scandinavica·H Teräväinen
Apr 1, 1990·Journal of Clinical Psychopharmacology·D Deptula, N Pomara
Feb 8, 1990·The New England Journal of Medicine·J R FarwellK B Nelson
Jan 1, 1989·Psychopharmacology·H S Koelega
Apr 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·S M MurphyP Tyrer
Jan 1, 1988·British Journal of Clinical Pharmacology·G Frcka, M Lader
Apr 1, 1987·International Clinical Psychopharmacology·I Hindmarch, J Z Bhatti
Oct 15, 1988·Annals of Internal Medicine·P A AdesM M LeWinter
Aug 1, 1988·British Journal of Clinical Pharmacology·D CurrieN A Wright
Jan 1, 1985·Psychopharmacology·D Olajide, M Lader
Jun 1, 1988·Perceptual and Motor Skills·C T Gualtieri, R W Evans
Jan 1, 1988·Psychopharmacology·G C PrestonS M Stahl
Jan 1, 1988·Psychopharmacology·C G SwiftB Tiplady
Jan 1, 1988·European Journal of Clinical Pharmacology·I Hindmarch, J Z Bhatti
May 1, 1987·British Journal of Clinical Pharmacology·I R EdwardsD MacIntosh
Feb 1, 1988·Journal of Clinical Psychopharmacology·J H Meador-WoodruffL Grunhaus

❮ Previous
Next ❯

Citations

Oct 25, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·J D PutzkeT J Boll
Dec 13, 2003·Comprehensive Psychiatry·Jonathan DowsonBarbara Sahakian
Dec 3, 2015·Annals of General Psychiatry·Eirini Tsitsipa, Konstantinos N Fountoulakis
Apr 20, 2006·International Journal of Clinical Practice·H G M Westenberg, C Sandner
May 19, 2005·Bipolar Disorders·Jonathan SavitzRajkumar Ramesar
Nov 27, 2008·Bipolar Disorders·Marc AdidaGuy M Goodwin
Apr 8, 2010·Human Psychopharmacology·Ian Hindmarch, Kenji Hashimoto
Jan 18, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J Benito-LeónF Bermejo-Pareja
Apr 5, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Marc AdidaPhilippe Courtet
Jan 21, 2010·Journal of Affective Disorders·Stein AnderssonUlrik F Malt
Jul 8, 2014·Journal of Affective Disorders·Kate O'Sullivan, Emily F Newman
Mar 25, 2011·Biological Psychiatry·Marc AdidaPhilippe Courtet
Aug 22, 2006·Behavioural Brain Research·A EnnaceurP L Chazot
May 18, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Friederike RampacherMichael Wagner
May 28, 2019·Neuropsychology Review·Catherine E Prado, Simon F Crowe

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.